CA3214915A1 - Radiopharmaceutical somatostatin receptor ligands and precursors thereof - Google Patents
Radiopharmaceutical somatostatin receptor ligands and precursors thereof Download PDFInfo
- Publication number
- CA3214915A1 CA3214915A1 CA3214915A CA3214915A CA3214915A1 CA 3214915 A1 CA3214915 A1 CA 3214915A1 CA 3214915 A CA3214915 A CA 3214915A CA 3214915 A CA3214915 A CA 3214915A CA 3214915 A1 CA3214915 A1 CA 3214915A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- unit
- acid
- compound
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/12—Organo silicon halides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/0472—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/008—Peptides; Proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21173849 | 2021-05-14 | ||
| EP21173849.7 | 2021-05-14 | ||
| PCT/EP2022/062985 WO2022238553A1 (en) | 2021-05-14 | 2022-05-12 | Radiopharmaceutical somatostatin receptor ligands and precursors thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3214915A1 true CA3214915A1 (en) | 2022-11-17 |
Family
ID=75936725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3214915A Pending CA3214915A1 (en) | 2021-05-14 | 2022-05-12 | Radiopharmaceutical somatostatin receptor ligands and precursors thereof |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240317780A1 (enExample) |
| EP (1) | EP4337270A1 (enExample) |
| JP (1) | JP2024517971A (enExample) |
| KR (1) | KR20240008341A (enExample) |
| CN (1) | CN117320759A (enExample) |
| AU (1) | AU2022273184A1 (enExample) |
| BR (1) | BR112023023890A2 (enExample) |
| CA (1) | CA3214915A1 (enExample) |
| IL (1) | IL308414A (enExample) |
| MX (1) | MX2023013485A (enExample) |
| WO (1) | WO2022238553A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117777296B (zh) * | 2024-02-28 | 2024-05-28 | 北京肿瘤医院(北京大学肿瘤医院) | B7h3亲和体及其诊疗核素标记物的制备方法与应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE070098T2 (hu) * | 2017-07-28 | 2025-05-28 | Univ Muenchen Tech | Kettõs módusú radioaktív jelzõ és terapeutikumok |
-
2022
- 2022-05-12 MX MX2023013485A patent/MX2023013485A/es unknown
- 2022-05-12 CA CA3214915A patent/CA3214915A1/en active Pending
- 2022-05-12 JP JP2023570394A patent/JP2024517971A/ja active Pending
- 2022-05-12 CN CN202280035052.5A patent/CN117320759A/zh active Pending
- 2022-05-12 KR KR1020237042809A patent/KR20240008341A/ko active Pending
- 2022-05-12 IL IL308414A patent/IL308414A/en unknown
- 2022-05-12 EP EP22729145.7A patent/EP4337270A1/en active Pending
- 2022-05-12 AU AU2022273184A patent/AU2022273184A1/en active Pending
- 2022-05-12 US US18/290,061 patent/US20240317780A1/en active Pending
- 2022-05-12 BR BR112023023890A patent/BR112023023890A2/pt unknown
- 2022-05-12 WO PCT/EP2022/062985 patent/WO2022238553A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| BR112023023890A2 (pt) | 2024-01-30 |
| IL308414A (en) | 2024-01-01 |
| WO2022238553A1 (en) | 2022-11-17 |
| US20240317780A1 (en) | 2024-09-26 |
| KR20240008341A (ko) | 2024-01-18 |
| AU2022273184A1 (en) | 2023-10-12 |
| MX2023013485A (es) | 2023-12-07 |
| EP4337270A1 (en) | 2024-03-20 |
| JP2024517971A (ja) | 2024-04-23 |
| CN117320759A (zh) | 2023-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES3011272T3 (en) | Dual mode radiotracer and -therapeutics | |
| ES2953196T3 (es) | Radiotrazador de modo dual de unión a PSMA y terapéutico | |
| ES2615805T3 (es) | Conjugados de antagonista de péptido análogo de la bombesina | |
| CN113677375B (zh) | 氟化硅受体取代的放射性药物及其前体 | |
| CA3214915A1 (en) | Radiopharmaceutical somatostatin receptor ligands and precursors thereof | |
| CA3211030A1 (en) | Dual mode radiotracer and therapeutics | |
| JP6410339B2 (ja) | 放射性核種標識オクトレオチド誘導体 | |
| US20250313579A1 (en) | Ligand compounds comprising a chelating group as a bridging group | |
| US20260027244A1 (en) | Silicon-based fluoride acceptor groups for radiopharmaceuticals | |
| WO2021121734A1 (en) | Modified grpr antagonist peptides for imaging and therapy of cancer | |
| Wurzer | Novel Structural Concepts for the Development of complex-based Radiopharmaceuticals and Ligand Systems | |
| EA052681B1 (ru) | Лигандные соединения, содержащие хелатирующую группу в качестве мостиковой группы | |
| KR20250011145A (ko) | 개선된 신장 청소율을 갖는 전립선-특이적 막 항원(psma) 리간드 | |
| JP2025532619A (ja) | イメージングおよび標的化放射線治療のための新規ミニガストリン由来コレシストキニン２受容体結合分子 | |
| WO2026012457A1 (zh) | 骨靶向放射性药物及其用途 | |
| CN120239618A (zh) | 放射性标记的psma配体化合物及其前体 | |
| EA046784B1 (ru) | Средства для диагностической визуализации ракового заболевания | |
| EA046402B1 (ru) | Двухрежимная радиоактивная метка и радиотерапевтическое средство |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250429 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250429 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20251203 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20251203 |